Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) FCF Margin (2019 - 2026)

Biodesix filings provide 8 years of FCF Margin readings, the most recent being 40.11% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 821.0% to 40.11% in Q1 2026 year-over-year; TTM through Mar 2026 was 26.12%, a 3432.0% increase, with the full-year FY2025 number at 26.59%, up 4615.0% from a year prior.
  • FCF Margin hit 40.11% in Q1 2026 for Biodesix, down from 2.41% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 2.41% in Q4 2025 to a low of 204.05% in Q1 2022.
  • Median FCF Margin over the past 5 years was 71.75% (2023), compared with a mean of 82.02%.
  • Biggest five-year swings in FCF Margin: crashed -16320bps in 2022 and later soared 8128bps in 2025.
  • Biodesix's FCF Margin stood at 144.46% in 2022, then grew by 28bps to 104.08% in 2023, then soared by 77bps to 24.16% in 2024, then soared by 110bps to 2.41% in 2025, then tumbled by -1767bps to 40.11% in 2026.
  • The last three reported values for FCF Margin were 40.11% (Q1 2026), 2.41% (Q4 2025), and 41.01% (Q3 2025) per Business Quant data.